NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 243 filers reported holding NEOGENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $192,680 | -23.5% | 15,665 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $251,737 | -7.7% | 15,665 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $272,728 | +54.0% | 15,665 | -18.3% | 0.00% | +33.3% |
| Q4 2022 | $177,149 | +19.7% | 19,172 | +11.2% | 0.00% | 0.0% |
| Q3 2022 | $148,000 | +1.4% | 17,242 | -3.8% | 0.00% | 0.0% |
| Q2 2022 | $146,000 | -30.5% | 17,926 | +3.9% | 0.00% | -25.0% |
| Q1 2022 | $210,000 | -60.6% | 17,258 | +10.5% | 0.00% | -55.6% |
| Q4 2021 | $533,000 | -54.5% | 15,613 | -35.7% | 0.01% | -60.9% |
| Q3 2021 | $1,171,000 | +6.8% | 24,283 | +0.1% | 0.02% | +4.5% |
| Q2 2021 | $1,096,000 | +73.7% | 24,269 | +85.6% | 0.02% | +57.1% |
| Q1 2021 | $631,000 | -16.8% | 13,076 | -7.1% | 0.01% | -26.3% |
| Q4 2020 | $758,000 | +46.6% | 14,076 | +0.5% | 0.02% | +26.7% |
| Q3 2020 | $517,000 | – | 14,010 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |